Dupont Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Dupont Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-18,900	Closed	-$1.02M	–	1055
2017 Q4	$1.02M	Sell	18,900 -1,800	-9%	-$98.5K	0.02%	508
2017 Q3	$1.18M	Buy	20,700 +1,092	+6%	+$64K	0.03%	490
2017 Q2	$1.18M	Sell	19,608 -3,792	-16%	-$216K	0.03%	489
2017 Q1	$1.27M	Buy	+23,400	New	+$1.15M	0.03%	461

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Dupont Capital Management's BIVV Position: Q1 2018 in Review

Dupont Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 18,900 shares — an estimated $1.02M sold.

Dupont Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.27M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Dupont Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Dupont Capital Management sold 18,900 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.02M.
Dupont Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Dupont Capital Management's Bioverativ Inc. Common Stock position peaked at $1.27M in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Dupont Capital Management's 13F filing for Q1 2018, filed 2 May 2018.